Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs Cefepime in Pediatric Bacterial Pneumonia
NCT01110421Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of doripenem in bacterial pneumonia, sponsored by Janssen Pharmaceutical. Started Dec 2010; status: terminated.
02
Drugs
doripenem
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on NCT01110421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110421.